IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
9 hedge funds and large institutions have $32.6M invested in IVERIC bio, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
+$11.5M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$7.49M |
| 3 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$5.39M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.7M |
| 5 |
VM
VHCP Management
New York
|
+$1.49M |
Top Sellers
ISEE Hedge Fund Activity: Q3 2013 in Review
9 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2013, worth a combined $32.6M.
Buyers outnumbered sellers: 9 funds opened new ISEE positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Independence Capital Asset Partners, opening a new position worth an estimated $11.5M.
- 9 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $32.6M of IVERIC bio, Inc. Common Stock stock for Q3 2013.
- 9 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2013 and 0 closed out, a net change of +9 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2013 was Independence Capital Asset Partners, an estimated $11.5M added.
Based on aggregated 13F filings for Q3 2013.